Rate Video

ASCO 2020 | Horizon scanning in lung cancer

Sanjay Popat • 11 Jun 2020

Lung Cancer Non-Small Cell Lung Cancer

Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, gives his perspective on where immunotherapy for patients with lung cancer will be heading in the next couple of years. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

PROMISE-meso: pembrolizumab vs. standard chemotherapy for mesothelioma

Sanjay Popat • 29 Sep 2019

Eagerly anticipated results of the FLAURA trial

Sanjay Popat • 8 Sep 2017

Perspectives on the CheckMate 9LA study

Sanjay Popat • 11 Jun 2020

Lung ART trial updates from ESMO 2020

Sanjay Popat • 2 Oct 2020

Related Videos

Updates on MRx0518 + pembro in patients with resistance to therapy

Alex Stevenson • 27 Nov 2020

STIMULI trial update at ESMO 2020

Dirk De Ruysscher • 16 Nov 2020

Exciting updates at the Gathering around Cancer meeting

Jarushka Naidoo • 4 Nov 2020

Osimertinib for EGFR-mutant lung cancer

Jarushka Naidoo • 4 Nov 2020